SCHEMBL25820621

SCHEMBL25820621

N#Cc1ccc2nccc(Nc3cccc(C(=O)Nc4cccc(Nc5ccccc5)c4)c3F)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 4/20 0.47
HTT P42858 1/20 0.45
DNMT3A Q9Y6K1 2/20 0.45
RXFP1 Q9HBX9 3/20 0.44
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
GRM4 Q14833 1/20 0.42
GAK O14976 1/20 0.42
RIPK2 O43353 1/20 0.42
COQ8A Q8NI60 1/20 0.42
NLK Q9UBE8 1/20 0.42
BRAF P15056 2/20 0.42
PKM P14618 1/20 0.41
MAPKAPK2 P49137 2/20 0.41
RAF1 P04049 1/20 0.41
NR1H4 Q96RI1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826555 0.95 MAPT (0.46) DNMT1HTTDNMT3ARXFP1MEN1
SCHEMBL24006018 0.89 DNMT1 (0.49) DNMT1HTTDNMT3ACCNCCDK8
SCHEMBL25820606 0.89 DNMT1 (0.51) DNMT1HTTDNMT3ARXFP1CCNC
SCHEMBL25820663 0.88 CDK8 (0.53) DNMT1HTTDNMT3ARXFP1CCNC
SCHEMBL25820620 0.88 DNMT1 (0.49) DNMT1HTTDNMT3ACCNCCDK8
SCHEMBL25820616 0.85 DNMT1 (0.51) DNMT1DNMT3ACCNCCDK8MEN1
SCHEMBL25487272 0.84 DNMT1 (0.48) DNMT1HTTDNMT3ARXFP1MAPT
SCHEMBL24010972 0.84 DNMT1 (0.64) DNMT1DNMT3ACCNCCDK8MAPT
SCHEMBL24003789 0.84 DNMT1 (0.59) DNMT1DNMT3ACCNCCDK8MAPT
SCHEMBL25820730 0.84 DNMT1 (0.64) DNMT1DNMT3ACCNCCDK8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885HTT 3124/4885DNMT3A 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.